You can find more information about isoleucine--tRNA ligase, putative using the following links:

PFID

PFID Old

Formal Annotation

PlasmoDB

TDR Targets

Subcellular Localization

Affecting Drugs

Drug Name

PubMed Articles (year of publication)

PF3D7_1225100

PFL1210w

isoleucine--tRNA ligase, putative

4-((1-phenyl-1H-benzo[d]imidazol-2-yl)thio)-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidine	Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug target
9-{[(2E)-4-(3,4-Dihydroxy-5-{[3-(3-hydroxy-2-butanyl)-2-oxiranyl]methyl}tetrahydro-2H-pyran-2-yl)-3-methyl-2-butenoyl]oxy}nonanoic acid	Using in Vitro Evolution and Whole Genome Analysis To Discover Next Generation Targets for Antimalarial Drug Discovery
Mupirocin	Validation of isoleucine utilization targets in Plasmodium falciparum Using genetic methods to define the targets of compounds with antimalarial activity
Reveromycin A	Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug target

PF3D7_1332900

PF13_0179

isoleucine--tRNA ligase, putative

(1R,2S,4aS,6aR,6bR,10R,12aS)-10-(((2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4S,5S)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)methyl)-1,2,6b,9,9,12a-hexamethyl-1,2,3,4,5,6,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a,6a-dicarboxylic acid	Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug target
2-Amino-3-(methylsulfanyl)butanoic acid	Using in Vitro Evolution and Whole Genome Analysis To Discover Next Generation Targets for Antimalarial Drug Discovery
Tcmdc-131575	Thousands of chemical starting points for antimalarial lead identification
Thiaisoleucine	Validation of isoleucine utilization targets in Plasmodium falciparum

Expasy - NiceZime View
Brenda - The Comprehensive Enzyme Information System